ELBM Electra shares move higher despite reporting a far wider than expected Q4 2025 per share loss Eli Lilly and Company LLY Q1 2026 Earnings Preview Growth Trajectory Analyst Expectations and Sector Implications NXTT Next CEO expresses strong optimism for AI and cloud segments to drive sustained longterm growth Gilead Sciences GILD Pipeline Milestones and Arcellx Acquisition Reinforce LongTerm Growth Trajectory in HIV and Oncology